Kyle GanoChief Business Development and Strategy Officer at Neurocrine Biosciences (NASDAQ: NBIX)
Dr. Kyle Gano, Chief Business Development and Strategy Officer, is responsible for business and corporate development activities, including the management of ongoing collaborations with AbbVie, BIAL, Mitsubishi Tanabe Pharma, and Voyager Therapeutics. Since joining Neurocrine Biosciences in 2001, Dr. Gano has held several positions of increasing responsibility across functions spanning marketing analytics to business development. Dr. Gano holds a Ph.D. in Organic Chemistry and a M.B.A. in Finance from the University of California, Los Angeles, a B.S. in Chemistry from the University of Oregon, and a B.S. in Biochemistry from the University of Washington.